Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioLine Rx Ltd receives orphan drug designation for novel stem cell mobilization treatment
BioLine Rx Ltd receives orphan drug designation for novel stem cell mobilization treatment
BioLine Rx Ltd receives orphan drug designation for novel stem cell mobilization treatment
Submitted by
admin
on January 23, 2014 - 7:51am
Source:
Reuters
News Tags:
stem cells
BioLineRx
BL-8040
AML
acute myeloid leukemia
Headline:
BioLine Rx Ltd receives orphan drug designation for novel stem cell mobilization treatment
Do Not Allow Advertisers to Use My Personal information
